These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 2267197)

  • 1. [Use of cyclosporin A in the treatment of Sezary's syndrome].
    Hellmann A; Koberda J; Siekierska-Hellmann M
    Pol Tyg Lek; 1990 May 21-28; 45(21-22):444-5. PubMed ID: 2267197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Remission of Sézary's syndrome with cyclosporin A. Mild capillary leak syndrome as an unusual side effect.
    Ramon D; Betlloch I; Jimenez A; Botella R; Castells A; Alberola V
    Acta Derm Venereol; 1986; 66(1):80-2. PubMed ID: 2424226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Sézary-Baccaredda syndrome].
    Alonso AM; Balassiano E; Bacha PC
    Med Cutan Ibero Lat Am; 1981; 9(4):303-6. PubMed ID: 7024683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Sézary's syndrome (author's transl)].
    Semrádová V
    Cesk Dermatol; 1979 Aug; 54(4):215-8. PubMed ID: 527054
    [No Abstract]   [Full Text] [Related]  

  • 5. [Sezary's syndrome (case report)].
    Miscević N; Suvajdzhić N; Jovanović V; Janković G; Radosević N; Colović M
    Srp Arh Celok Lek; 1995; 123(3-4):102-4. PubMed ID: 16296236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Morphological changes in the skin and blood in Sézary's syndrome].
    Tsvetkova GM; Persina IS; Padarian GN
    Arkh Patol; 1982; 44(1):66-9. PubMed ID: 7065927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Asymmetric polyarthritis in Sézary's syndrome].
    del Río Garma J; Gómez Rodríguez N; Graña Gil J; Sánchez Bursón JM; Yebra Pimentel MT; Galdo Fernández F
    Rev Clin Esp; 1993 Feb; 192(2):83-5. PubMed ID: 8460240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Sezary's syndrome. Clinical, hematological and evolutive aspects].
    Crespo V; Ramírez G; Lendoyro A
    Actas Dermosifiliogr; 1978; 69(7-8):197-208. PubMed ID: 717080
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment of therapy-resistant Sézary syndrome with Cyclosporin-A: suppression of pruritus, leukaemic T cell activation markers and tumour mass.
    Tötterman TH; Scheynius A; Killander A; Danersund A; Alm GV
    Scand J Haematol; 1985 Feb; 34(2):196-203. PubMed ID: 3883480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of Sézary syndrome with cyclosporin A.
    Puttick L; Pollock A; Fairburn E
    J R Soc Med; 1983 Dec; 76(12):1063-5. PubMed ID: 6608586
    [No Abstract]   [Full Text] [Related]  

  • 11. Utility of flow cytometry immunophenotyping and DNA ploidy studies for diagnosis and characterization of blood involvement in CD4+ Sézary's syndrome.
    Lima M; Almeida J; dos Anjos Teixeira M; Queiros ML; Santos AH; Fonseca S; Balanzategui A; Justica B; Orfao A
    Haematologica; 2003 Aug; 88(8):874-87. PubMed ID: 12935975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of cutaneous T-cell lymphomas with TP-5. Evaluation of the clinical effect in 8 patients.
    Przybilla B; Burg G; Schmoeckel C; Braun-Falco O
    Acta Derm Venereol; 1983; 63(6):524-9. PubMed ID: 6198843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Sézary's syndrome and Sézary's cells (author's transl)].
    Prunieras M
    Dermatologica; 1978; 157(6):371-6. PubMed ID: 363475
    [No Abstract]   [Full Text] [Related]  

  • 14. 13-cis-retinoic acid effective in mycosis fungoides. A report from the Scandinavian Mycosis Fungoides Group.
    Thomsen K; Molin L; Volden G; Lange Wantzin G; Hellbe L
    Acta Derm Venereol; 1984; 64(6):563-6. PubMed ID: 6084938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sézary's syndrome: a clinical evaluation of eight patients.
    Hamminga L; Hartgrink-Groeneveld CA; van Vloten WA
    Br J Dermatol; 1979 Mar; 100(3):291-6. PubMed ID: 435387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic characterization of Sézary's syndrome by conventional cytogenetics and cross-species color banding fluorescent in situhybridization.
    Espinet B; Salido M; Pujol RM; Florensa L; Gallardo F; Domingo A; Servitje O; Estrach T; Garcìa-Muret P; Woessner S; Serrano S; Solé F
    Haematologica; 2004 Feb; 89(2):165-73. PubMed ID: 15003891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A case of Sezary's syndrome with terminal "leukemic phase".
    Specchia G; Tursi A; Liso V; Errico G; Bonomo L
    Haematologica; 1981 Jun; 66(3):279-88. PubMed ID: 6793457
    [No Abstract]   [Full Text] [Related]  

  • 18. [Cyclosporin A: a new immunosuppressive peptide].
    Wu J
    Sheng Li Ke Xue Jin Zhan; 1985 Jan; 16(1):41-4. PubMed ID: 3890171
    [No Abstract]   [Full Text] [Related]  

  • 19. Cytobiological studies and pathogenetic speculations in an atypical case of Sezary's syndrome.
    Paterlini P; Ricciotti M; Cretara G; D'Alessandro E; Franchi A; Quaglino D
    Haematologica; 1983; 68(5):581-90. PubMed ID: 6416938
    [No Abstract]   [Full Text] [Related]  

  • 20. [Sézary's syndrome (author's transl)].
    Dosková M; Havlícek F; Belsan I; Lukásová M; Malasková V
    Cas Lek Cesk; 1980 Oct; 119(42):1141-4. PubMed ID: 7285076
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.